BridgeMD
New treatment option for Allergy
Official title Study of Indoor Air Pollutants and Their Impact in Children's Health and Wellbeing
ClinicalTrials.gov ID: NCT07402200
What this study is testing
- What it's testing
- The goal of this study is to identify and assess in real time the impact of the combined action of various types of air and dust pollutants within a classroom on children's health and quality of life, particularly regarding atopic/allergic diseases in children, and on potential exposure to pollutants at home. Participants will answer questionnaires regarding their health and medications, undergo allergy tests, perform non-invasive lung function tests and check blood oxygen levels.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 12
You may be able to join if
- Child included in the SynAir-G observational study
- Child and caregiver(s) willing to follow the study procedures
- Written informed consent from the child's parents/guardians
- For case group, at least one positive answer (yes) to any of the following questions and for control group, negative answers to all the following...
- For case group: Diagnosis of asthma/allergic rhinitis/eczema/food allergy (based on SYNAIR-G baseline questionnaire), active during the past year.
You likely can't join if
- Child or child's parents/guardians who:
- Refuse to participate in the project / to give informed consent.
- Do not want to follow the protocol procedures.
- Do not read or/and write in French.
- Plan a long stay outside the region that does not allow them to follow the visit plan.
- The child is not affiliated to the French social security service
See the full eligibility criteria
- Child included in the SynAir-G observational study
- Child and caregiver(s) willing to follow the study procedures
- Written informed consent from the child's parents/guardians
- For case group, at least one positive answer (yes) to any of the following questions and for control group, negative answers to all the following questions based on the baseline questionnaire administered in the...
- For case group: Diagnosis of asthma/allergic rhinitis/eczema/food allergy (based on SYNAIR-G baseline questionnaire), active during the past year.
- For control group: absence of diagnosis of asthma/allergic rhinitis/eczema/food allergy (based on SYNAIR-G baseline questionnaire)
- Child or child's parents/guardians who:
- Refuse to participate in the project / to give informed consent.
- Do not want to follow the protocol procedures.
- Do not read or/and write in French.
- Plan a long stay outside the region that does not allow them to follow the visit plan.
- The child is not affiliated to the French social security service
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.